Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/35376
Title: COVID-19 in multiple sclerosis and neuromyelitis optica spectrum disorder patients in Latin America
Authors: Alonso, Ricardo
Silva, Berenice
Garcea, Orlando
Correa Diaz, Patricio E.
dos Passos, Giordani Rodrigues
Ramirez Navarro, Deyanira A.
Garcia Valle, Luis A.
Rodriguez Salinas, Luis C.
Negrotto, Laura
Luetic, Geraldine
Tkachuk, Veronica A.
Miguez, Jimena
Diaz de Bedoya, Fernando Hamuy
Goiry, Lorna Galleguillos
Ramirez Sanchez, Nicia E.
Burgos, Marcos
Steinberg, Judith
Balbuena, Maria E.
Monterrey Alvarez, Priscilla
Lopez, Pablo A.
Ysrraelit, Maria C.
Leon, Rosalba A.
Cohen, Aron Benzadon
Gracia, Fernando
Molina, Omaira
Casas, Magdalena
Deri, Norma H.
Pappolla, Agustin
Patrucco, Liliana
Cristiano, Edgardo
Tavolini, Dario
Nadur, Debora
Granda, Ana M. Toral
Weiser, Roberto
Cassara, Fatima Pagani
Sinay, Vladimiro
Carcamo Rodriguez, Claudia
Lazaro, Luciana G.
Menichini, Maria L.
Piedrabuena, Raul
Orozco Escobar, Geraldine
Carra, Adriana
Chertcoff, Anibal
Santos Pujols, Biany
Vrech, Carlos
Tarulla, Adriana
Carvajal, Rene
Mainella, Carolina
Becker, Jefferson
PEETERS, Liesbet 
Walton, Clare
Alonso Serena, Marina
Nunez, Sebastian
Rojas, Juan, I
Issue Date: 2021
Publisher: ELSEVIER SCI LTD
Source: Multiple sclerosis and related disorders (Print), 51 , p. 102886 (Art N° 102886)
Abstract: Background: There is no data regarding COVID-19 in Multiple Sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD) patients in Latin America. Objective: The objective of this study was to describe the clinical characteristics and outcomes of patients included in RELACOEM, a LATAM registry of MS and NMOSD patients infected with COVID-19. Methods: RELACOEM is a longitudinal, strictly observational registry of MS and NMOSD patients who suffer COVID-19 and Dengue in LATAM. Inclusion criteria to the registry were either: (1) a biologically confirmed COVID-19 diagnosis based on a positive result of a COVID-19 polymerase chain reaction (PCR) test on a naso-pharyngeal swab; or (2) COVID-19-typical symptoms (triad of cough, fever, and asthenia) in an epidemic zone of COVID-19. Descriptive statistics were performed on demographic and clinical variables. The cohort was later stratified for MS and NMOSD and univariate and multivariate logistic regression analysis was performed to identify variables associated with hospitalizations/intensive critical units (ICU) admission. Results: 145 patients were included in the registry from 15 countries and 51 treating physicians. A total of 129 (89%) were MS patients and 16 (11%) NMOSD. 81.4% patients had confirmed COVID-19 and 18.6% were suspected cases. 23 (15.8%) patients were hospitalized, 9 (6.2%) required ICU and 5 (3.4 %) died due to COVID-19. In MS patients, greater age (OR 1.17, 95% CI 1.05 - 1.25) and disease duration (OR 1.39, 95%CI 1.14-1.69) were associated with hospitalization/ICU. In NMOSD patients, a greater age (54.3 vs. 36 years, p=<0.001), increased EDSS (5.5 vs 2.9, p=0.0012) and disease duration (18.5 vs. 10.3 years, p=0.001) were significantly associated with hospitalization/ICU. Conclusion: we found that in MS patients, age and disease duration was associated with hospitalization and ICU admission requirement, while age, disease duration and EDSS was associated in NMOSD.
Notes: Alonso, R (corresponding author), Univ Buenos Aires, Fac Med, Hosp Ramos Mejia, Ctr Univ Esclemsis Multiple CUEM, Urquiza 609,C1221 ADC, Caba, Argentina.
Keywords: multiple sclerosis; NMOSD; COVID-19; registries; Latin America
Document URI: http://hdl.handle.net/1942/35376
ISSN: 2211-0348
e-ISSN: 2211-0356
DOI: 10.1016/j.msard.2021.102886
ISI #: WOS:000689354300013
Rights: © 2021 Elsevier B.V. All rights reserved.
Category: A1
Type: Journal Contribution
Validations: ecoom 2022
Appears in Collections:Research publications

Files in This Item:
File Description SizeFormat 
1-s20-S221103482100153X-main.pdfPublished version935.43 kBAdobe PDFView/Open
Show full item record

WEB OF SCIENCETM
Citations

31
checked on May 2, 2024

Page view(s)

40
checked on Sep 7, 2022

Download(s)

14
checked on Sep 7, 2022

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.